Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Innovation Adoption Is Key UK Challenge Says MedTech Directorate

Standing still is not an option if the health care system is to remain sustainable

Executive Summary

The UK’s MedTech Directorate is pressing ahead with 16 separate initiatives under its recently issued medtech strategy. It all adds to the sense that 2023 will be a major year for UK medtech.

You may also be interested in...



Unfair Bias In Device Design: UK MHRA And Government Promise Action

A 15-month UK independent review of ethnic and other biases in device design has called for treatment inequity to be addressed at the highest levels of government, more resources for the MHRA and equity assessments to be included in approvals and post market surveillance.

UK Pro-Innovation Report Offers Promise For Medtech With MHRA/NICE Alignment

Report to government underlines need for faster, parallel evaluation of medtech and healthtech innovation and recommends bigger role for MHRA alongside work done by approved bodies on UKCA file processing.

UK Diagnostics Companies Count On Medtech Strategy To Deliver

The UK government’s first ever medtech strategy has received plaudits for its ambition. The diagnostics industry, while supportive of the intent, is waiting for more than just promises.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147716

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel